SERNOVA CORP. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4 CAD | -1.23% |
|
-9.09% | -42.86% |
| 04-02 | Sernova Corp. Provides Positive Clinical and Platform Portfolio Update | CI |
| 03-19 | Sernova Corp. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
Chart calendar Sernova Corp.
a8b9.Y5LNY-_O5Yu_K39jz-9tWLsiqJcr6xKJCDb_wSlPROQ.Nqe4DJmB1vrNUiw7msIca-J0mdETiiW9XlOZ8kcOHrIq9JIxpYi2x49PHA~5af2c3a923c2fe6ba575da35dd10a1e1
Upcoming events on Sernova Corp.
Past events on Sernova Corp.
| 30/04/2024 18:00 | Annual General Meeting |
| 17/04/2024 14:30 | Bloom Burton & Co. Healthcare Investor Conference |
| 19/03/2024 18:30 | ROTH Conference |
| 18/03/2024 23:57 | Q1 2024 Earnings Release |
| 29/01/2024 12:07 | Q4 2023 Earnings Release |
| 07/01/2024 | Investor Meeting |
| 07/11/2023 | Truist Securities Healthcare Conference |
| 27/10/2023 16:30 | IPITA IXA CTRMS Joint Congress - Abstract # 205.1 |
| 26/10/2023 22:45 | IPITA IXA CTRMS Joint Congress - Abstract # 105.1 |
| 25/10/2023 | IPITA IXA CTRMS Joint Congress |
| 10/10/2023 | Cell & Gene Meeting on the Mesa Conference |
| 05/10/2023 15:00 | Business Update Call |
| 22/09/2023 15:00 | Executive Update Call |
| 14/09/2023 02:19 | Q3 2023 Earnings Release |
| 10/09/2023 | H.C. Wainwright Global Investment Conference |
| 27/06/2023 19:15 | Symposia Cel Truist Securities Cell Therapy Symposium |
| 25/06/2023 01:15 | American Diabetes Association Scientific Session - Abstract No 240 OR |
| 14/06/2023 00:24 | Q2 2023 Earnings Release |
| 04/06/2023 | BIO International Convention |
| 27/04/2023 18:00 | Annual General Meeting |
Annual results
| Fiscal Period | October | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -3,95 -3,56 -11.02% | -5,03 -8,81 42.85% | -6,67 -4,84 -37.75% | -24,3 -23,9 -1.94% | -40,1 -30,9 -29.56% | -33,9 |
|
EBIT Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -6,94 -7,00 0.91% | -24,8 -22,6 -9.53% | -40,5 -31,7 -27.77% | -31,3 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -3,97 -3,95 -0.54% | -5,32 -1,83 -190.78% | -6,97 -5,94 -17.26% | -24,4 -22,9 -6.52% | -39,0 -32,4 -20.2% | -31,3 |
|
Net income Million CAD | Released Forecast Spread | -3,97 -3,95 -0.54% | -5,32 -1,83 -190.78% | -6,97 -5,39 -29.31% | -24,4 -22,9 -6.52% | -39,0 -32,4 -20.2% | -31,3 |
|
EPS CAD | Released Forecast Spread | -0,02 -0,02 0% | -0,04 -0,01 -300% | -0,03 -0,02 -100% | -0,09 -0,08 -12.5% | -0,13 -0,11 -23.81% | -0,11 |
| Announcement Date | 14/02/20 | 01/02/21 | 14/02/22 | 26/01/23 | 29/01/24 | - |
Quarterly results
| Fiscal Period | October | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | ||
|
EBITDA Million CAD | Released Forecast Spread | -5,36 -2,20 -143.78% | -4,82 -2,80 -72.21% | -5,79 -4,80 -20.72% | -8,33 -5,90 -41.26% | -8,50 -5,50 -54.57% | -9,70 -6,00 -61.65% | -10,2 -6,50 -56.37% | -9,92 -9,50 -4.46% | -7,70 | -7,10 | -5,80 | |||
|
EBIT Million CAD | Released Forecast Spread | -8,45 -6,10 -38.55% | -8,61 -6,70 -28.48% | -9,81 -7,00 -40.11% | |||||||||||
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -5,83 -5,70 -2.31% | -8,21 -5,87 -39.95% | -8,02 -6,50 -23.31% | -9,35 -6,80 -37.45% | -9,93 -7,96 -24.85% | -11,7 -8,04 -45.6% | -9,34 | -9,99 | ||||||
|
Net income Million CAD | Released Forecast Spread | -5,83 -5,70 -2.31% | -8,21 -5,87 -39.95% | -8,02 -6,50 -23.31% | -9,35 -6,80 -37.45% | -9,93 -7,96 -24.85% | -11,7 -8,04 -45.6% | -9,34 | -9,99 | ||||||
|
EPS CAD | Released Forecast Spread | -0,02 -0,01 -100% | -0,02 -0,01 -100% | -0,02 -0,02 0% | -0,03 -0,02 -50% | -0,03 -0,02 -50% | -0,03 -0,02 -50% | -0,03 -0,03 -20% | -0,04 -0,02 -100% | -0,03 -0,03 0% | -0,03 | -0,03 | -0,03 | -0,03 | -0,03 |
| Announcement Date | 29/03/22 | 27/06/22 | 14/09/22 | 26/01/23 | 16/03/23 | 13/06/23 | 13/09/23 | 29/01/24 | 18/03/24 | - | - | - | - | - |
More events
Past sector events for Sernova Corp.
| 02/05/2024 11:00 | ENOVIS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | GLAUKOS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 07:00 | SMITH & NEPHEW PLC: Q1 2024 Sales and Revenue Release - Trading Update |
| 30/04/2024 | JAPAN LIFELINE CO., LTD.: Q4 2023 Earnings Release |
| 30/04/2024 21:05 | STRYKER CORPORATION: Q1 2024 Earnings Release |
| 30/04/2024 21:01 | AXONICS, INC.: Q1 2024 Earnings Release |
| 29/04/2024 | DOUBLE MEDICAL TECHNOLOGY INC.: Q1 2024 Earnings Release |
| 28/04/2024 | BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO., LTD.: Q1 2024 Earnings Release |
| 27/04/2024 | YANTAI ZHENGHAI BIOTECHNOLOGY CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | SINO MEDICAL SCIENCES TECHNOLOGY INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SVA Stock
- Calendar Sernova Corp.
